Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and safety of tryptophan as an immune cell activator
jRCTs041220025Completed
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of l-tryptophan. Primary endpoint: Changes in blood concentrations of tryptophan and related metabolites. Started May 2022; status: completed.
02
Drugs
l-tryptophan
Beyond the preview
Go deeper on jRCTs041220025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041220025.